GlassScriptPhysician profile
Zayd Adnan Eldadah
NPI 1184679920
$358,468.06
in general payments reported to CMS, 2019-2025
29 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $13K · 2021: $10K · 2022: $109K · 2023: $103K · 2024: $86K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $166K · Travel and Lodging: $28K · Food and Beverage: $8,953 · Education: $80.63 · Grant: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $165,600.00 |
| Travel and Lodging | $28,424.41 |
| Food and Beverage | $8,952.52 |
| Education | $80.63 |
| Grant | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $261,642.32 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abbott Laboratories | $59,995.19 | 2019-2025 | Accent, Aveir, Ensite |
| Biotronik INC. | $13,947.57 | 2019-2021 | |
| Boston Scientific Corporation | $8,427.38 | 2019-2025 | Acuity Steerable, General - Therapies, Ingevity+ |
| Cardiva Medical, INC. | $6,035.83 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 5f Vcs |
| Medtronic Vascular, INC. | $2,574.82 | 2019-2020 | |
| Biosense Webster, INC. | $1,642.80 | 2022-2025 | Carto 3 |
| Altathera Pharmaceuticals LLC | $1,000.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $569.45 | 2020-2023 | |
| Medtronic, INC. | $564.91 | 2023-2025 | Cobalt Dr Mri Surescan, Pulseselect, Micra |
| Medical Device Business Services, INC. | $450.00 | 2020 | |
| Cvrx, INC. | $401.78 | 2020-2023 | Barostim Neo System |
| Acutus Medical, INC. | $242.81 | 2020-2021 | |
| Zoll Respicardia, INC. | $172.26 | 2021 | |
| Novo Nordisk INC | $137.52 | 2022-2024 | Wegovy, Ozempic, Rybelsus |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $117.46 | 2019-2021 | |
| Ebr Systems, INC. | $97.57 | 2025 | |
| Kestra Medical Technology Services, INC. | $92.73 | 2023-2025 | Assure Wcd |
| Cardiofocus, INC. | $92.50 | 2022 | |
| Philips North America LLC | $55.49 | 2025 | Mcot |
| E.R. Squibb & Sons, L.L.C. | $49.08 | 2020-2025 | Camzyos, Eliquis |
| Amgen INC. | $41.03 | 2024-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $37.59 | 2023 | Optimizer |
| Irhythm Technologies, INC. | $26.32 | 2024 | Zio Monitor, Zio Xt Patch |
| Baxter Healthcare | $19.60 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $19.52 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.53 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zayd Eldadah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.